Document is current
Any future updates will be listed below
-
Authors
Osawa, Kosuke
Ohya, Masaki
Yamamoto, Shuto
Nakashima, Yuri
Tanaka, Yusuke
Yamano, Yukiko
Takatsuka, Taisuke
Araki, Shin-ichi https://orcid.org/0000-0002-2933-0316
- License Information
-
More Information
Article History
Received: 13 August 2024
Accepted: 3 November 2024
First Online: 16 November 2024
Declarations
:
: Ohya M received lecture fees from Kyowa Kirin Co. Ltd., and Ono Pharmaceutical Co. Ltd. Araki S received lecture fees from Kyowa Kirin Co., Ltd., AstraZeneca Co., Ltd., and Mitsubishi Tanabe Pharma Corporation and received research grants from Kyowa Kirin Co., Ltd. and Torii Pharmaceutical Co., Ltd. Other authors declare that they have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Wakayama Medical University Ethics (IRB approval number 3670) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: According to the Guidelines for Epidemiological Studies of the Ministry of Health, Labor, and Welfare of Japan, written informed consent was not required owing to the retrospective nature of this study.
